Chronic caffeine administration exacerbates renovascular, but not genetic, hypertension in rats
- PMID: 3020089
- PMCID: PMC423756
- DOI: 10.1172/JCI112659
Chronic caffeine administration exacerbates renovascular, but not genetic, hypertension in rats
Abstract
The purpose of this study was to determine whether or not caffeine would exacerbate renovascular hypertension. Therefore, we examined the effects of chronic caffeine administration on arterial blood pressure in rats subjected to either unilateral renal artery clipping (2K-1C rats) or sham-operation. Animals in each group were randomly assigned to receive either 0.1% caffeine in their drinking water or normal drinking water, and systolic blood pressure was monitored for 6 wk. Caffeine markedly exacerbated the severity of hypertension in 2K-1C rats and caused histological changes consistent with malignant hypertension. 6 wk after surgery, systolic blood pressure, plasma renin activity, and creatinine clearance in control 2K-1C rats were 169 +/- 5 mmHg (mean +/- SEM), 4.4 +/- 0.5 ng AI X ml-1 X h-1, and 2.9 +/- 0.2 ml/min, respectively; as compared with 219 +/- 4 mmHg, 31.8 +/- 7.8 ng AI X ml-1 X h-1, and 1.4 +/- 0.3 ml/min, respectively, in 2K-1C rats receiving caffeine (all values were significantly different compared with control 2K-1C). Chronic caffeine administration did not alter systolic blood pressure, plasma renin activity, or creatinine clearance in sham-operated rats or spontaneously hypertensive rats. Chronic treatment with enalapril (a converting enzyme inhibitor) prevented the development of hypertension in control 2K-1C rats and caffeine-treated 2K-1C rats; however, withdrawal of enalapril precipitated a rapid rise in systolic blood pressure in caffeine-treated 2K-1C rats, but not in control 2K-1C rats. These experiments indicate that caffeine specifically exacerbates experimental renovascular hypertension and might worsen the hypertensive process in patients with renovascular hypertension.
Similar articles
-
Reversion of cardiovascular remodelling in renovascular hypertensive 2K-1C rats by renin-angiotensin system inhibitors.Clin Exp Pharmacol Physiol. 2020 Dec;47(12):1965-1977. doi: 10.1111/1440-1681.13384. Epub 2020 Aug 14. Clin Exp Pharmacol Physiol. 2020. PMID: 32688435
-
Different mechanisms maintaining high blood pressure in chronic one-kidney, one-clip, and two-kidney, one-clip hypertensive rats.Clin Exp Hypertens A. 1983;5(3):429-45. doi: 10.3109/10641968309069498. Clin Exp Hypertens A. 1983. PMID: 6188560
-
AT1 and TxA2/PGH2 receptors maintain hypertension throughout 2K,1C Goldblatt hypertension in the rat.Am J Physiol. 1996 Oct;271(4 Pt 2):R891-6. doi: 10.1152/ajpregu.1996.271.4.R891. Am J Physiol. 1996. PMID: 8897978
-
The sympathetic nervous system in clinical and experimental hypertension.Kidney Int. 1986 Sep;30(3):437-52. doi: 10.1038/ki.1986.204. Kidney Int. 1986. PMID: 3537449 Review.
-
[Functional alteration of nervous system in renovascular hypertension].Yakugaku Zasshi. 2009 Feb;129(2):185-9. doi: 10.1248/yakushi.129.185. Yakugaku Zasshi. 2009. PMID: 19182445 Review. Japanese.
Cited by
-
Methylxanthines and the kidney.Handb Exp Pharmacol. 2011;(200):391-412. doi: 10.1007/978-3-642-13443-2_15. Handb Exp Pharmacol. 2011. PMID: 20859805 Free PMC article. Review.
-
Is Coffee and Tea a Threat or Ally to Cardiovascular Health?Cureus. 2023 Dec 5;15(12):e49991. doi: 10.7759/cureus.49991. eCollection 2023 Dec. Cureus. 2023. PMID: 38186410 Free PMC article. Review.
-
Thyroid hormone stimulates 5'-ecto-nucleotidase of neonatal rat ventricular myocytes.Mol Cell Biochem. 2004 Oct;265(1-2):195-201. doi: 10.1023/b:mcbi.0000044396.31443.a8. Mol Cell Biochem. 2004. PMID: 15543949
-
Adenosine inhibits renin release induced by suprarenal-aortic constriction and prostacyclin.Naunyn Schmiedebergs Arch Pharmacol. 1989 May;339(5):590-5. doi: 10.1007/BF00167266. Naunyn Schmiedebergs Arch Pharmacol. 1989. PMID: 2570363
-
Methylxanthines augment the renin response to suprarenal-aortic constriction.Naunyn Schmiedebergs Arch Pharmacol. 1989 Jun;339(6):690-6. doi: 10.1007/BF00168663. Naunyn Schmiedebergs Arch Pharmacol. 1989. PMID: 2570368
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical